Subscribe to Newsletter

Business Practice

Discovery & Development Technology and Equipment

Your Guide to Equipment Orchestration in the Lab

| Malka Hoffmann | 4 min read

You’ve got the lab, the tools, and the equipment; now, you need integration and orchestration for a seamless workflow.

Business & Regulation Business Practice

Breaking Down Brain Barriers

| Agnese Cattaneo | 3 min read

As mental health disorders escalate, pharmaceutical innovators can harness advanced tools to accelerate much-needed treatments.

Discovery & Development Drug Discovery

The Golden Ticket For GLP-1 Development

| Stephanie Vine | 6 min read

We speak to the 2025 winner of Novo Nordisk and Pioneer Group’s Golden Ticket program.

Manufacture Facilities

FUJIFILM Diosynth and Regeneron Sign 10-Year, $3 Billion Manufacturing Agreement

| Stephanie Vine | 2 min read

FUJIFILM Diosynth to manufacture biologics for Regeneron at new facility in Holly Springs, North Carolina.

Manufacture Contract Development Services

Partnerships To Be Precise

| Elizabeth Hickman, Dave Miller | 3 min read

In the highly regulated precision medicine development sector, the agility and expertise of a CDMO can make or break a commercial drug candidate.

Business & Regulation Standards & Regulation

Trump Speech Suggests Pharma Tariffs Incoming

| Stephanie Vine | 2 min read

Donald Trump threatens “major tariff” on pharmaceuticals.

Business & Regulation Business Practice

The Trump Effect on Cell and Gene: Science versus Shockwaves

| 9 min read

Audrey Greenberg on FDA staffing cuts, Peter Marks’ resignation, CDMO pressure, IP migration, AI acceleration, and what CGT needs now to stay on track

Business & Regulation Standards & Regulation

The Future of the NIH

| Hernan Bazan | 2 min read

Thoughts on the US National Institutes of Health and its role in funding research for non-opioid therapeutics.

Manufacture Advanced Medicine

Building a Resilient CGT Workforce

| Daniel Palmacci | 3 min read

With competition for skilled employees in cell and gene therapy manufacturing high, companies need to invest in training and mentorship.

Business & Regulation Business Practice

Calling Out Misleading Information

| Rob Coker | 2 min read

FDA letter sent to Edenbridge Pharmaceuticals demonstrates the challenges of getting pharma advertising right.


Latest White Papers

Performance validation of ScatterX78 against NIST reference materials

| Contributed by Malvern Panalytical

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

All White Papers

Sister Publications

You might be interested in our Sister Publications:

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register